Polak PE, Kalinin S, Dello RC, Gavrilyuk V, Sharp A, Peters JM, Richardson J, Willson TM, Weinberg G, Feinstein DL: Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005, 168: 65-75. 10.1016/j.jneuroim.2005.07.006.
Article
CAS
PubMed
Google Scholar
Rapin I, Katzman R: Neurobiology of autism. Ann Neurol. 1998, 43: 7-14. 10.1002/ana.410430106.
Article
CAS
PubMed
Google Scholar
Newschaffer CJ, Fallin D, Lee NL: Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol Rev. 2002, 24: 137-153. 10.1093/epirev/mxf010.
Article
PubMed
Google Scholar
Folstein SE, Rosen-Sheidley B: Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet. 2001, 2: 943-955. 10.1038/35103559.
Article
CAS
PubMed
Google Scholar
Korvatska E, Van de WJ, Anders TF, Gershwin ME: Genetic and immunologic considerations in autism. Neurobiol Dis. 2002, 9: 107-125. 10.1006/nbdi.2002.0479.
Article
CAS
PubMed
Google Scholar
Lipkin WI, Hornig M: Microbiology and immunology of autism spectrum disorders. Novartis Found Symp. 2003, 251: 129-143.
Article
CAS
PubMed
Google Scholar
Stubbs EG: Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr. 1976, 6: 269-274. 10.1007/BF01543467.
Article
CAS
PubMed
Google Scholar
Stubbs EG, Crawford ML: Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977, 7: 49-55. 10.1007/BF01531114.
Article
CAS
PubMed
Google Scholar
Warren RP, Margaretten NC, Pace NC, Foster A: Immune abnormalities in patients with autism. J Autism Dev Disord. 1986, 16: 189-197. 10.1007/BF01531729.
Article
CAS
PubMed
Google Scholar
Denney DR, Frei BW, Gaffney GR: Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996, 26: 87-97. 10.1007/BF02276236.
Article
CAS
PubMed
Google Scholar
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005, 57: 67-81. 10.1002/ana.20315.
Article
CAS
PubMed
Google Scholar
Pardo CA, Vargas DL, Zimmerman AW: Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005, 17: 485-495. 10.1080/02646830500381930.
Article
PubMed
Google Scholar
Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Court, Altaye M, Wills-Karp M: Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. 2006, 172: 198-205. 10.1016/j.jneuroim.2005.11.007.
Article
CAS
PubMed
Google Scholar
Berger J, Wagner JA: Physiological and therapeutic roles of peroxisome proliferator-activated receptors. Diabetes Technol Ther. 2002, 4: 163-174. 10.1089/15209150260007381.
Article
CAS
PubMed
Google Scholar
Duval C, Chinetti G, Trottein F, Fruchart JC, Staels B: The role of PPARs in atherosclerosis. Trends Mol Med. 2002, 8: 422-430. 10.1016/S1471-4914(02)02385-7.
Article
CAS
PubMed
Google Scholar
Bongartz T, Coras B, Vogt T, Scholmerich J, Muller-Ladner U: Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford). 2005, 44: 126-129. 10.1093/rheumatology/keh423.
Article
CAS
Google Scholar
Gniadecki R, Calverley MJ: Emerging drugs in psoriasis. Expert Opin Emerg Drugs. 2002, 7: 69-90. 10.1517/14728214.7.1.69.
Article
CAS
PubMed
Google Scholar
Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, Mayumi T: A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology. 2003, 124: 1315-1324. 10.1016/S0016-5085(03)00262-2.
Article
CAS
PubMed
Google Scholar
Liang HL, Ouyang Q: [A clinical trial of rosiglitazone and 5-aminosalicylate combination for ulcerative colitis]. Zhonghua Nei Ke Za Zhi. 2006, 45: 548-551.
CAS
PubMed
Google Scholar
Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD: An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol. 2001, 96: 3323-3328.
CAS
PubMed
Google Scholar
Wada K, Nakajima A, Blumberg RS: PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease. Trends Mol Med. 2001, 7: 329-331. 10.1016/S1471-4914(01)02076-7.
Article
CAS
PubMed
Google Scholar
Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, Feinstein DL: Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem. 2003, 278: 5828-5836. 10.1074/jbc.M208132200.
Article
CAS
PubMed
Google Scholar
Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Dello RC: Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?. Biochem Pharmacol. 2005, 70: 177-188. 10.1016/j.bcp.2005.03.033.
Article
CAS
PubMed
Google Scholar
Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung. 1997, 47: 29-35.
CAS
PubMed
Google Scholar
Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E: Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry. 2006, 163: 1252-1263. 10.1176/appi.ajp.163.7.1252.
Article
PubMed
Google Scholar
Kennedy DP, Redcay E, Courchesne E: Failing to deactivate: resting functional abnormalities in autism. Proc Natl Acad Sci U S A. 2006, 103: 8275-8280. 10.1073/pnas.0600674103.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gillies PS, Dunn CJ: Pioglitazone. Drugs. 2000, 60: 333-343. 10.2165/00003495-200060020-00009.
Article
CAS
PubMed
Google Scholar
Hanefeld M, Belcher G: Safety profile of pioglitazone. Int J Clin Pract Suppl. 2001, 27-31.
Google Scholar
Saenger P, Dabiri G, Jones K, Krebs J, Sun Y, Mudd P, Weston WM, Cobitz AR, Freed MI, Porter LE: Diabetes in childhood - Benefits of rosiglitazone in children with type 2 diabetes mellitus. Program and abstracts of the European Association for the Study of Diabetes 41st Annual Meeting. 2005, 133-
Google Scholar
Zdravkovic V, Hamilton JK, Daneman D, Cummings EA: Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes. J Pediatr. 2006, 149: 845-849. 10.1016/j.jpeds.2006.08.049.
Article
CAS
PubMed
Google Scholar
Landreth G: PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease. Exp Neurol. 2006, 199: 245-248. 10.1016/j.expneurol.2006.04.006.
Article
CAS
PubMed
Google Scholar
Feinstein DL: Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther. 2003, 5: 67-73. 10.1089/152091503763816481.
Article
CAS
PubMed
Google Scholar
Gupta S, Aggarwal S, Heads C: Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996, 26: 439-452. 10.1007/BF02172828.
Article
CAS
PubMed
Google Scholar
Singh VK: Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol. 1996, 66: 143-145. 10.1016/0165-5728(96)00014-8.
Article
CAS
PubMed
Google Scholar
Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook JA: Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol. 2003, 171: 6827-6837.
Article
CAS
PubMed
Google Scholar
Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK: Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2002, 168: 2508-2515.
Article
CAS
PubMed
Google Scholar
O'Byrne PM: Cytokines or their antagonists for the treatment of asthma. Chest. 2006, 130: 244-250. 10.1378/chest.130.1.244.
Article
PubMed
Google Scholar
Mueller C, Weaver V, Vanden Heuvel JP, August A, Cantorna MT: Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys. 2003, 418: 186-196. 10.1016/j.abb.2003.08.006.
Article
CAS
PubMed
Google Scholar
Marteleto MR, Pedromonico MR: Validity of Autism Behavior Checklist (ABC): preliminary study. Rev Bras Psiquiatr. 2005, 27: 295-301.
Article
PubMed
Google Scholar
Wadden NP, Bryson SE, Rodger RS: A closer look at the Autism Behavior Checklist: discriminant validity and factor structure. J Autism Dev Disord. 1991, 21: 529-541. 10.1007/BF02206875.
Article
CAS
PubMed
Google Scholar
Volkmar FR, Cicchetti DV, Dykens E, Sparrow SS, Leckman JF, Cohen DJ: An evaluation of the Autism Behavior Checklist. J Autism Dev Disord. 1988, 18: 81-97. 10.1007/BF02211820.
Article
CAS
PubMed
Google Scholar
Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN: Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999, 14: 388-394.
Article
CAS
PubMed
Google Scholar
Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ: Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003, 112: e420-10.1542/peds.112.5.e420.
Article
PubMed
Google Scholar
Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, Dunn M, Hyman SL, McMahon WM, Goudie-Nice J, Hepburn S, Minshew N, Rogers S, Sigman M, Spence MA, Tager-Flusberg H, Volkmar FR, Lord C: Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study. J Autism Dev Disord. 2006, 36: 317-324. 10.1007/s10803-005-0071-0.
Article
PubMed
Google Scholar
Gupta S, Aggarwal S, Rashanravan B, Lee T: Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. 1998, 85: 106-109. 10.1016/S0165-5728(98)00021-6.
Article
CAS
PubMed
Google Scholar
Singh VK, Warren RP, Odell JD, Cole P: Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol. 1991, 61: 448-455. 10.1016/S0090-1229(05)80015-7.
Article
CAS
PubMed
Google Scholar
Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK: Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest. 1990, 19: 245-251.
Article
CAS
PubMed
Google Scholar
Yonk LJ, Warren RP, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK: CD4+ helper T cell depression in autism. Immunol Lett. 1990, 25: 341-345. 10.1016/0165-2478(90)90205-5.
Article
CAS
PubMed
Google Scholar
Lee KS, Park SJ, Hwang PH, Yi HK, Song CH, Chai OH, Kim JS, Lee MK, Lee YC: PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J. 2005, 19: 1033-1035. 10.1096/fj.04-2591hyp.
Article
CAS
PubMed
Google Scholar
Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS: Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis. 2002, 8: 330-339. 10.1097/00054725-200209000-00004.
Article
PubMed
Google Scholar
Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997, 89: 587-596. 10.1016/S0092-8674(00)80240-8.
Article
CAS
PubMed
Google Scholar
Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, Killeen N, Urban JF, Guo L, Paul WE: Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004, 5: 1157-1165. 10.1038/ni1128.
Article
CAS
PubMed
Google Scholar
Owley T, Walton L, Salt J, Guter SJ, Winnega M, Leventhal BL, Cook EH: An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2005, 44: 343-348. 10.1097/01.chi.0000153229.80215.a0.
Article
PubMed
Google Scholar
King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH: Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2001, 40: 658-665. 10.1097/00004583-200106000-00010.
Article
CAS
PubMed
Google Scholar
Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y: Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry. 2006, 45: 1196-1205. 10.1097/01.chi.0000231976.28719.2a.
Article
PubMed
Google Scholar
Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F: Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004, 114: e634-e641. 10.1542/peds.2003-0264-F.
Article
PubMed
Google Scholar
Resetkova E, Morita T, Akasu F, Carayon P, Volpe R: In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med. 1993, 16: 256-264.
CAS
PubMed
Google Scholar
Shah Y, Morimura K, Gonzalez F: Expression of Peroxisome Proliferator-Activated Receptor-{gamma} in Macrophage Suppresses Experimentally-Induced Colitis. Am J Physiol Gastrointest Liver Physiol. 2006
Google Scholar
Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P: PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut. 2006, 55: 1341-1349. 10.1136/gut.2006.093484.
Article
PubMed Central
CAS
PubMed
Google Scholar
Snider LA, Swedo SE: PANDAS: current status and directions for research. Mol Psychiatry. 2004, 9: 900-907. 10.1038/sj.mp.4001542.
Article
CAS
PubMed
Google Scholar
Swedo SE, Garvey M, Snider L, Hamilton C, Leonard HL: The PANDAS subgroup: recognition and treatment. CNS Spectr. 2001, 6: 419-6.
CAS
PubMed
Google Scholar
Comments
View archived comments (1)